GR1008018B - Λιπιδικα συμπλοκα αποτελουμενα απο ανιονικα λυσο-λιπιδια και η εφαρμογη αυτων - Google Patents
Λιπιδικα συμπλοκα αποτελουμενα απο ανιονικα λυσο-λιπιδια και η εφαρμογη αυτωνInfo
- Publication number
- GR1008018B GR1008018B GR20120100446A GR20120100446A GR1008018B GR 1008018 B GR1008018 B GR 1008018B GR 20120100446 A GR20120100446 A GR 20120100446A GR 20120100446 A GR20120100446 A GR 20120100446A GR 1008018 B GR1008018 B GR 1008018B
- Authority
- GR
- Greece
- Prior art keywords
- anionic
- lysolipids
- lipid assemblies
- lipids
- lipid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Η παρούσα εφαρμογή σχετίζεται με λιπιδικά σύμπλοκα, συστάσεις και λιποσωμικά συστήματα παράδοσης τα οποία αποτελούνται από ανιονικά λιπίδια μονής αλυσίδας, και την χρησιμοποίησή τους σε διαγνωστικές και θεραπευτικές εφαρμογές. Περιλαμβάνει τη χρήση ανιονικών λυσο-λιπιδίων με σκοπό την τροποποίηση του φορτίου μιας κατιονικής λιπιδικής σύστασης η οποία με τη σειρά της αποτελείται από τουλάχιστον ένα είδος κατιονικού λιπιδίου, προαιρετικά σε συνδυασμό με ένα ή περισσότερα ουδέτερα λιπίδια ή και ένα ή περισσότερα ανιονικά λιπίδια.
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GR20120100446A GR1008018B (el) | 2012-09-06 | 2012-09-06 | Λιπιδικα συμπλοκα αποτελουμενα απο ανιονικα λυσο-λιπιδια και η εφαρμογη αυτων |
US14/425,830 US9730893B2 (en) | 2012-09-06 | 2013-09-05 | Lipid assemblies comprising anionic lysolipids and use thereof |
EP13756909.1A EP2892505B1 (en) | 2012-09-06 | 2013-09-05 | Lipid assemblies comprising anionic lysolipids and use thereof |
CA2882523A CA2882523C (en) | 2012-09-06 | 2013-09-05 | Lipid assemblies comprising anionic lysolipids and use thereof |
PCT/EP2013/068359 WO2014037436A1 (en) | 2012-09-06 | 2013-09-05 | Lipid assemblies comprising anionic lysolipids and use thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GR20120100446A GR1008018B (el) | 2012-09-06 | 2012-09-06 | Λιπιδικα συμπλοκα αποτελουμενα απο ανιονικα λυσο-λιπιδια και η εφαρμογη αυτων |
Publications (1)
Publication Number | Publication Date |
---|---|
GR1008018B true GR1008018B (el) | 2013-10-29 |
Family
ID=49115532
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR20120100446A GR1008018B (el) | 2012-09-06 | 2012-09-06 | Λιπιδικα συμπλοκα αποτελουμενα απο ανιονικα λυσο-λιπιδια και η εφαρμογη αυτων |
Country Status (5)
Country | Link |
---|---|
US (1) | US9730893B2 (el) |
EP (1) | EP2892505B1 (el) |
CA (1) | CA2882523C (el) |
GR (1) | GR1008018B (el) |
WO (1) | WO2014037436A1 (el) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3122365B1 (en) * | 2014-03-25 | 2023-05-03 | Arcturus Therapeutics, Inc. | Transthyretin allele selective una oligomers for gene silencing |
AU2015236215B2 (en) | 2014-03-25 | 2020-03-19 | Arcturus Therapeutics, Inc. | UNA oligomers having reduced off-target effects in gene silencing |
US9856475B2 (en) | 2014-03-25 | 2018-01-02 | Arcturus Therapeutics, Inc. | Formulations for treating amyloidosis |
JP6830441B2 (ja) | 2015-04-01 | 2021-02-17 | アークトゥラス・セラピューティクス・インコーポレイテッドArcturus Therapeutics,Inc. | 治療上のunaオリゴマーおよびその使用 |
WO2017015671A1 (en) | 2015-07-23 | 2017-01-26 | Arcturus Therapeutics, Inc. | Compositions for treating amyloidosis |
KR101713118B1 (ko) * | 2015-08-28 | 2017-03-10 | 서강대학교산학협력단 | 세포외기질 전달용 리포솜 |
JP6399530B1 (ja) * | 2017-09-04 | 2018-10-03 | 一丸ファルコス株式会社 | pH感受性リポソーム |
CN110724734B (zh) * | 2019-10-22 | 2020-06-16 | 北京恩泽康泰生物科技有限公司 | 含miRNA mimic的人造脂质体及其制备方法与应用 |
CN113694040B (zh) * | 2020-05-20 | 2023-05-30 | 中山大学孙逸仙纪念医院 | 一种基于dppa的治疗性脂质体纳米粒子及其制备方法及应用 |
CN113350286B (zh) * | 2021-05-22 | 2022-07-26 | 南开大学 | “水桥”介导超响应的功能协同两性离子脂质及其制备方法和应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2586708A1 (en) | 2004-11-05 | 2006-05-11 | Novosom Ag | Improvements in or relating to pharmaceutical compositions comprising an oligonucleotide as an active agent |
AU2005306075A1 (en) | 2004-11-19 | 2006-05-26 | Novosom Ag | Improvements in or relating to pharmaceutical compositions for local administration |
ES2419106T3 (es) | 2005-12-01 | 2013-08-19 | Pronai Therapeutics, Inc. | Formulación de liposomas anfóteros |
-
2012
- 2012-09-06 GR GR20120100446A patent/GR1008018B/el active IP Right Grant
-
2013
- 2013-09-05 WO PCT/EP2013/068359 patent/WO2014037436A1/en active Application Filing
- 2013-09-05 EP EP13756909.1A patent/EP2892505B1/en not_active Not-in-force
- 2013-09-05 CA CA2882523A patent/CA2882523C/en not_active Expired - Fee Related
- 2013-09-05 US US14/425,830 patent/US9730893B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
WO2014037436A1 (en) | 2014-03-13 |
CA2882523A1 (en) | 2014-03-13 |
US9730893B2 (en) | 2017-08-15 |
EP2892505B1 (en) | 2016-11-16 |
CA2882523C (en) | 2021-06-15 |
US20150216803A1 (en) | 2015-08-06 |
EP2892505A1 (en) | 2015-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2882523C (en) | Lipid assemblies comprising anionic lysolipids and use thereof | |
HK1209021A1 (en) | Nanotherapeutics for drug targeting | |
TR201816986T4 (tr) | Terapötik ajan iletim formülasyonlarına yönelik lipitler. | |
HK1198924A1 (en) | Targeting aminoacid lipids | |
MX2021000012A (es) | Vehiculo todo terreno de asientos laterales. | |
CA2868034C (en) | Ionizable cationic lipids | |
ZA201502352B (en) | Liposomal drug delivery system | |
IN2014DN10889A (el) | ||
EP2873678A4 (en) | PEPTIDE PENETRATING IN A CELL, CONJUGATED COMPRISING SAME, AND COMPOSITION COMPRISING SAME | |
GB201106750D0 (en) | Novel compounds | |
WO2014057362A3 (en) | Omega -3 compositions | |
WO2012116073A3 (en) | Amphiphilic dendron-coils, micelles thereof and uses | |
PH12015500664A1 (en) | Pharmaceutical combinations comprising dual angiopoietin-2/dll4 binders and anti-vegf-r agents | |
MX2015003262A (es) | Composicion farmaceutica topica. | |
AP2014007399A0 (en) | Phenyl-3-AZA-bicycloÄ3.1.0Ühex-3-YL-methanones andthe use thereof as medicament | |
WO2014039533A3 (en) | Preventing pulmonary recurrence of cancer with lipid-complexed cisplatin | |
MY191932A (en) | Chitosan-derived compositions | |
HK1204563A1 (en) | Topical ophthalmological pharmaceutical composition containing pazopanib | |
WO2012154942A3 (en) | Ceramide anionic liposome compositions | |
MX357284B (es) | Compuestos de quinona para tratar enfermedades mediadas por ape1. | |
EP2720708A4 (en) | AIMING AT THE NEUROMUSCULAR END PLATE FOR TREATMENT PURPOSES | |
PH12015500663A1 (en) | Pharmaceutical combinations comprising dual angiopoietin-2/dll4 binders and anti-vegf-r agents | |
IL235363A0 (en) | Means for releasing pesticides | |
UA117567C2 (uk) | Композиція, яка стимулює лактацію, на основі фосфатидилсерину | |
NZ705930A (en) | A pharmaceutical composition comprising a solid nanoparticle and at least an antigen for the treatment against an intracellular pathogenic agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PG | Patent granted |
Effective date: 20131118 |